USPTO Deadlines
Next Deadline
967 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-06-21)
Due Date
June 21, 2028
Grace Period Ends
December 21, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
36 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 4, 2025 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Mar 1, 2024 | CHLD | M | CHANGE OF OWNER RECEIVED FROM IB | Loading... |
| Oct 25, 2022 | FINV | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Oct 5, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Oct 5, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 21, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 21, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jun 21, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 5, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 5, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 8, 2022 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 28, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 25, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 25, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 25, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 25, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 25, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 21, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 21, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 21, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 14, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Feb 14, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jan 28, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 28, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 28, 2022 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Jan 28, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 28, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 28, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jan 25, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jan 24, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 9, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 5, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 30, 2021 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Oct 22, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Additional Information
Design Mark
The mark consists of three connected partial ovals.
Classification
International Classes
005